Ambra Hernis

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Evaluating long non-coding RNA signatures as biomarkers for inflammatory pathway regulation and rehabilitative outcomes in Parkinson's disease: toward a precision medicine approach.

Evaluating long non-coding RNA signatures as biomarkers for inflammatory pathway regulation and rehabilitative outcomes in Parkinson's disease: toward a precision medicine approach.

Journal: Frontiers in immunology
Published: February 02, 2026

Irisin hampers β-amyloid-induced microglial inflammation via the miR-451a/TLR4/NLRP3 axis.

Irisin hampers β-amyloid-induced microglial inflammation via the miR-451a/TLR4/NLRP3 axis.

Journal: Frontiers in immunology
Published: December 05, 2025

Neuroinflammatory Signature of Post-Traumatic Confusional State: The Role of Cytokines in Moderate-to-Severe Traumatic Brain Injury.

Neuroinflammatory Signature of Post-Traumatic Confusional State: The Role of Cytokines in Moderate-to-Severe Traumatic Brain Injury.

Journal: International journal of molecular sciences
Published: July 18, 2025

Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.

Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.

Journal: Biomolecules
Published: June 19, 2025

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 10, 2023

The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation.

The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation.

Journal: Frontiers in immunology
Published: September 21, 2023

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.

Journal: International journal of molecular sciences
Published: March 30, 2023

Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study.

Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study.

Journal: Frontiers in immunology
Published: March 21, 2023

Modulation of Neuroendocrine and Immunological Biomarkers Following Rehabilitation in Sarcopenic Patients.

Modulation of Neuroendocrine and Immunological Biomarkers Following Rehabilitation in Sarcopenic Patients.

Journal: Cells
Published: May 31, 2022

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.

Journal: Frontiers in immunology
Published: May 18, 2022

Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.

Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.

Journal: Frontiers in neurology
Published: December 01, 2021

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease.

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 30, 2021
Showing 1-12 of 29

Last Updated: 09/26/2026